<DOC>
	<DOCNO>NCT02159859</DOCNO>
	<brief_summary>The purpose study determine amount ertapenem blood time hemodialysis session .</brief_summary>
	<brief_title>Pharmacokinetics Optimal Dose Ertapenem Hemodialysis Patients</brief_title>
	<detailed_description>After hemodialysis session , subject administer ertapenem amount ertapenem blood measure seven time period initiation next hemodialysis session .</detailed_description>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Ertapenem</mesh_term>
	<criteria>Men woman age 18 88 time admission Oakwood Hospital Medical Center January 1 , 2014 date Institutional Review Board ( IRB ) approval December 1 , 2015 Diagnosed end stage renal disease require hemodialysis three time week No allergy Î² lactam medication Existing IV access parenteral ertapenem infusion Willing blood draw , predose , 0.5 , 1 , 2 , 6 , 12 hour posthemodialysis prehemodialysis follow hemodialysis No evidence hepatic disease No history alcoholism drug abuse within pervious 2 year Not pregnant History form epilepsy , seizure convulsion Currently take form valproic acid divalproex sodium treatment disease state Currently take probenecid Current Clostridium difficile ( C . diff . ) infection , define 30 day prior day1 receive ertapenem study Currently receive antimicrobial agent prophylaxis treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>88 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>ertapenem</keyword>
	<keyword>pharmacokinetic</keyword>
	<keyword>pharmacodynamics</keyword>
	<keyword>hemodialysis</keyword>
	<keyword>require hemodialysis three time week</keyword>
</DOC>